We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Whitepapers

Tumor Microenvironment Explained content piece image
Whitepaper

Tumor Microenvironment Explained

Immuno-oncology research investigates how the immune system interacts with cancer cells within the tumor microenvironment, a process which is not fully understood.
Phenotypic and Functional Characterization of CAR-T Cells content piece image
Whitepaper

Phenotypic and Functional Characterization of CAR-T Cells

The successful use of immunotherapies to help combat cancer has expanded rapidly in the last few years, with many therapies now approved for clinical use.
Improved RT-qPCR Could Transform Diagnostics content piece image
Whitepaper

Improved RT-qPCR Could Transform Diagnostics

Download this whitepaper to discover how to overcome the limitations of PCR testing, how RT-qPCR will impact diagnostics both in lab and at point of care and how RT-qPCR is driving new methods and applications.
Whitepaper

Accelerating Cancer Immune Cell Therapies

As we have gained a greater understanding of cancer biology, therapeutic interventions have evolved from a one-size-fits-all approach to more targeted approaches, which afford patients not only longer lives but increased quality of life.
Best Practices for Air Sampling in Veterinary Environments content piece image
Whitepaper

Best Practices for Air Sampling in Veterinary Environments

The quality of indoor air dramatically affects the health of animals and humans during livestock production. Airborne transmission has been suspected of being responsible for epidemics of highly infectious diseases in livestock production, and due to the COVID-19 pandemic, there has been increasing concern about the role of wild animals in the epidemiology of most zoonoses.
Autologous CAR T-Cell Manufacturing content piece image
Whitepaper

Autologous CAR T-Cell Manufacturing

Cell-based chimeric antigen receptor (CAR) T-cell therapies have rapidly advanced from preclinical research. This success has driven an influx of companies to further develop CAR T-cell constructs to make them more effective, safe and persistent.
Challenging Host Cell Protein Assays for Improved Risk Mitigation content piece image
Whitepaper

Challenging Host Cell Protein Assays for Improved Risk Mitigation

At high levels, host cell proteins (HCPs) can cause immunogenic responses and reduced efficacy of biologics, so it is imperative to have an effective, robust HCP assay to detect them and mitigate these effects.
Validation Guidance for Residual Host Cell DNA Testing content piece image
Whitepaper

Validation Guidance for Residual Host Cell DNA Testing

Development of a manufacturing process for a biotherapeutic that ensures consistent quality, purity and safety is a critical step in successfully developing the drug, getting it approved by regulatory agencies, and bringing it to the market.
Advancing the Development of Therapeutics Against Infectious Diseases content piece image
Whitepaper

Advancing the Development of Therapeutics Against Infectious Diseases

Novel and emerging infectious diseases can be a serious threat to human health and the global economy, as exhibited by the current SARS-CoV-2 outbreak. To mitigate these threats, it is necessary to initiate comprehensive containment strategies such as
Reliable Results from Cell-Based Bioassays content piece image
Whitepaper

Reliable Results from Cell-Based Bioassays

While common laboratory plastics are generally regarded as inert by researchers, some commonly used products such as pipette tips and sample tubes have been reported to leach chemical compounds including oleamide, erucamide and DiHEMDA.
Advertisement